MedTrace Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 41

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $30M

  • Investors
  • 10

MedTrace General Information

Description

Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The company's devices automate bedside production and infusion of radioactive water in the PET scanner suite and consist of a remotely operated unit producing the radioactive water to innovate PET diagnostic imaging by transforming blood flow quantification, enabling physicians to get a platform that assists them to focus on heart-study applications, brain and tumour vascularization and diabetes studies.

Contact Information

Website
www.medtrace.dk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Agern Allé 5A
  • 2970 Hørsholm
  • Denmark
+45 31 00 00 00

MedTrace Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedTrace Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 11-May-2021 $30M 000.00 Completed Clinical Trials - Phase 3
6. Later Stage VC 08-Apr-2020 00.000 00.000 Completed Clinical Trials - Phase 3
5. Early Stage VC 03-Jul-2019 Completed Pre-Clinical Trials
4. Grant 14-Dec-2015 00000 Completed Pre-Clinical Trials
3. Early Stage VC 01-Sep-2015 Completed Pre-Clinical Trials
2. Grant 22-Jan-2015 $80K Completed Startup
1. Accelerator/Incubator Completed Startup
To view MedTrace’s complete valuation and funding history, request access »

MedTrace Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The com
Diagnostic Equipment
Hørsholm, Denmark
41 As of 2022
000.00
00000000000 000.00

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000000000 000000000
Lansing, MI
00 As of 0000
000.00
00000000000 000.00

000000

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000000000000 00000000
Redwood City, CA
000 As of 0000
00000
0.00 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedTrace Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ionetix Venture Capital-Backed Lansing, MI 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Redwood City, CA 000 00000 000000000000
000000 0000000 Private Debt Financed Milan, Italy 0000 00000 000000000 00 00000
You’re viewing 3 of 3 competitors. Get the full list »

MedTrace Patents

MedTrace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3338808-A1 Diagnostic usages of short-lived radiopharmaceuticals Pending 21-Dec-2016 0000000000
AU-2017382935-A1 An infusion system for short-lived radiopharmaceuticals Pending 21-Dec-2016 000000000
AU-2017382946-A1 Diagnostic usages of short-lived radiopharmaceuticals Pending 21-Dec-2016 0000000000
US-11285225-B2 Diagnostic usages of short-lived radiopharmaceuticals Active 21-Dec-2016 0000000000 0
CA-3044341-A1 An infusion system for short-lived radiopharmaceuticals Pending 21-Dec-2016 A61M5/007
To view MedTrace’s complete patent history, request access »

MedTrace Executive Team (5)

Name Title Board Seat Contact Info
Martin Stenfeldt Chief Executive Officer
Rune Kristensen Co-Founder, Chief Strategy Officer & Chief Operating Officer
You’re viewing 2 of 5 executive team members. Get the full list »

MedTrace Board Members (11)

Name Representing Role Since
Cesare Orlandi MD Self Board Member 000 0000
Claus Møller MD Self Board Member 000 0000
Erik Strömqvist Self Chairman 000 0000
Mads Rasmussen Accelerace Vice-Chairman of the Board 000 0000
Robert Schier Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

MedTrace Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedTrace Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BankInvest Group Asset Manager Minority 000 0000 000000 0
Swisscanto Private Equity Asset Manager Minority 000 0000 000000 0
The ATP Group Limited Partner Minority 000 0000 000000 0
Verve Ventures Venture Capital Minority 000 0000 000000 0
VF Venture Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »